Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Seminars in Cancer Biology
|
February 14, 2021
Tackling cancer cell dormancy: Insights from immune models, and transplantation
Alexandre Corthay, Tibor Bakacs, Govindarajan Thangavelu, et al.
Pharmacological Research
|
April 17, 2012
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)
Tibor Bakacs, Jitendra N Mehrishi, Miklós Szabó, et al.
Cureus
|
May 19, 2021
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
Ralf Kleef, Viktor Bacher, Robert Nagy, et al.
Cureus
|
April 4, 2022
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Tibor Bakacs, Rifaat Safadi, László G Puskás, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2020
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Csaba Kerepesi, Tibor Bakacs, Ralph W Moss, et al.
Integrative Cancer Therapies
|
September 9, 2018
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
Ralf Kleef, Ralph Moss, A Marcell Szasz, et al.
Infectious Disorders Drug Targets
|
April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients
Tibor Bakacs, Volker Sandig, Shimon Slavin, et al.
Scandinavian Journal of Immunology
|
October 8, 2019
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer
Tibor Bakacs, Ralph W Moss, Ralf Kleef, et al.
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Seminars in Cancer Biology
|
February 14, 2021
Tackling cancer cell dormancy: Insights from immune models, and transplantation
Alexandre Corthay, Tibor Bakacs, Govindarajan Thangavelu, et al.
Pharmacological Research
|
April 17, 2012
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)
Tibor Bakacs, Jitendra N Mehrishi, Miklós Szabó, et al.
Cureus
|
May 19, 2021
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
Ralf Kleef, Viktor Bacher, Robert Nagy, et al.
Cureus
|
April 4, 2022
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Tibor Bakacs, Rifaat Safadi, László G Puskás, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2020
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Csaba Kerepesi, Tibor Bakacs, Ralph W Moss, et al.
Integrative Cancer Therapies
|
September 9, 2018
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
Ralf Kleef, Ralph Moss, A Marcell Szasz, et al.
Infectious Disorders Drug Targets
|
April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients
Tibor Bakacs, Volker Sandig, Shimon Slavin, et al.
Scandinavian Journal of Immunology
|
October 8, 2019
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer
Tibor Bakacs, Ralph W Moss, Ralf Kleef, et al.
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Page
of 2